Bertotti Santiago, Fleming Ian, Cámara María de Los Milagros, Centeno Cameán Camila, Carmona Santiago J, Agüero Fernán, Balouz Virginia, Zahn Astrid, Di Noia Javier M, Alfonzo Juan D, Buscaglia Carlos A
Laboratory of Molecular Biology of Protozoa, Instituto de Investigaciones Biotecnológicas 'Dr Rodolfo Ugalde' (IIBio, Universidad Nacional de San Martín, UNSAM, and Consejo Nacional de Investigaciones Científicas y Técnicas, CONICET), Av. 25 de Mayo y Francia, Campus UNSAM, San Martín (1650), Buenos Aires, Argentina.
Department of Microbiology, The Ohio State University, 318 W 12th Ave. (Aronoff Building), Columbus, U.S.A.
Biochem J. 2022 Feb 17;479(4):561-580. doi: 10.1042/BCJ20210850.
Adenosine-to-inosine conversion at position 34 (A34-to-I) of certain tRNAs is essential for expanding their decoding capacity. This reaction is catalyzed by the adenosine deaminase acting on tRNA (ADAT) complex, which in Eukarya is formed by two subunits: ADAT2 and ADAT3. We herein identified and thoroughly characterized the ADAT molecules from the protozoan pathogen Trypanosoma cruzi, the causative agent of Chagas Disease. TcADAT2 and TcADAT3 spontaneously form a catalytically active complex, as shown by expression in engineered bacteria and/or by the increased ex vivo tRNA A-to-I deamination activity of T. cruzi epimastigotes overexpressing TcADAT subunits. Importantly, enhanced TcADAT2/3 activity in transgenic parasites caused a shift in their in vivo tRNAThrAGU signature, which correlated with significant changes in the expression of the Thr-rich TcSMUG proteins. To our knowledge, this is the first evidence indicating that T. cruzi tRNA editing can be modulated in vivo, in turn post-transcriptionally changing the expression of specific genes. Our findings suggest tRNA editing/availability as a forcible step in controlling gene expression and driving codon adaptation in T. cruzi. Moreover, we unveil certain differences between parasite and mammalian host tRNA editing and processing, such as cytosine-to-uridine conversion at position 32 of tRNAThrAGU in T. cruzi, that may be exploited for the identification of novel druggable targets of intervention.
某些转运RNA(tRNA)第34位的腺苷到肌苷的转换(A34到I)对于扩展其解码能力至关重要。该反应由作用于tRNA的腺苷脱氨酶(ADAT)复合物催化,在真核生物中,该复合物由两个亚基组成:ADAT2和ADAT3。我们在此鉴定并全面表征了来自原生动物病原体克氏锥虫(恰加斯病的病原体)的ADAT分子。TcADAT2和TcADAT3自发形成具有催化活性的复合物,这在工程菌中的表达以及/或者在过表达TcADAT亚基的克氏锥虫前鞭毛体的体外tRNA A到I脱氨活性增加中得到了证明。重要的是,转基因寄生虫中增强的TcADAT2/3活性导致其体内tRNAThrAGU特征发生变化,这与富含苏氨酸的TcSMUG蛋白表达的显著变化相关。据我们所知,这是第一个表明克氏锥虫tRNA编辑可以在体内被调节的证据,进而在转录后改变特定基因的表达。我们的发现表明tRNA编辑/可用性是控制克氏锥虫基因表达和驱动密码子适应的一个有力步骤。此外,我们揭示了寄生虫和哺乳动物宿主tRNA编辑与加工之间的某些差异,例如克氏锥虫中tRNAThrAGU第32位的胞嘧啶到尿嘧啶的转换,这可能被用于识别新的可药物干预靶点。